slides · global inventory
Callout
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 96,741
Current window 87,571-87,600
Pages 3,225
Rows per page 30
Component
87,571-87,600 of 96,741
40
The slide uses heatmaps to show genetic associations, contrasting immune and cancer phenotypes for specific proteins.23andMe | Investor Presentation Deck | 57 slides · 23andMe
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
49
The slide features a gradient background with scattered DNA base letters (A, T, C, G) and a large number '5' in a circle, indicating it is the fifth section.23andMe | Investor Presentation Deck | 57 slides · 23andMe
Pitch deck Investor relations 1 hit
53
Includes a callout highlighting the growth in Therapeutics R&D investment.23andMe | Investor Presentation Deck | 57 slides · 23andMe
Pitch deck Investor relations 1 hit
11
The slide uses a green callout box to emphasize the deal structure.AbCellera | Investor Conference Presentation Deck | 19 slides · AbCellera
Conference presentation Investor relations Beat · Evidence & Proof1 hit
11
The slide uses a circular process diagram to represent the flywheel effect of their platform.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Solution1 hit
13
The slide uses a process flow diagram to illustrate the transition from biological wet-lab data generation to AI model training.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Evidence1 hit
15
The diagram is a circular flywheel process showing the integration of data, wet lab validation, and AI creation.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Action1 hit
07
Includes two testimonials from Key Opinion Leaders (KOLs) to emphasize the patient burden.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
10
The slide outlines a multi-part clinical trial design with specific dosing cohorts and patient eligibility requirements.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution1 hit
12
Aeglea BioTherapeutics | Investor Presentation Deck | 37 slidesAeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution1 hit
13
ADA stands for Anti-Drug Antibodies.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution1 hit
17
The slide presents two distinct clinical metrics: a box plot for arginine levels and a bar chart for patient response rates.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Loop · Jobs To Be Done1 hit
18
Clinical trial data presentation with statistical significance markers and MCID thresholds.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Loop · Jobs To Be Done1 hit
19
The slide uses a heatmap to visualize individual patient outcomes, highlighting clinical improvement vs. worsening.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Loop · Jobs To Be Done1 hit
20
Clinical trial safety data comparing Pegzilarginase to Placebo.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Loop · Jobs To Be Done1 hit
24
The slide uses a biological pathway diagram to explain the mechanism of action of the drug candidate.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
36
The table highlights specific clinical response metrics for six individual patients, demonstrating improvements and normalization of mobility scores.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
03
The slide includes a footnote explaining F/X adjusted metrics.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · Financials1 hit
04
The slide uses TTM (Trailing Twelve-Month) metrics to show sales trends and composition.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · Financials1 hit
05
The chart includes a callout bubble highlighting the growth rate.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · Financials1 hit
06
The chart shows a decline in operating income over the trailing twelve-month periods.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · Financials1 hit
08
The slide includes a footnote explaining the impact of Rivian Automotive investment valuation changes on the net income figures.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · Financials1 hit
09
The slide uses a dual-chart layout to compare revenue growth against operating profitability.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · Segment Results1 hit
12
The chart shows negative cash flow values improving over time.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · Long-Term GoalLoop · Cost Of Inaction1 hit
13
The chart displays negative values (outflows) narrowing over time, indicating improved cash flow performance.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · Long-Term GoalLoop · Cost Of Inaction1 hit
14
The chart displays negative values (cash outflows/investments) narrowing over time.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · Long-Term GoalLoop · Cost Of Inaction1 hit
15
The chart highlights the stability of share counts over time, supporting the goal of managing dilution.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations 1 hit
05
The slide uses a circular photo collage of patients to emphasize the human element of the treatment goals.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · WhatLoop · Golden Circle1 hit
11
The slide uses a hub-and-spoke visual metaphor to connect the clinical class to the list of autoantibodies.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · HowLoop · Golden Circle1 hit
12
The slide uses a pyramid-like structure to display patient population sizes for different medical conditions.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · HowLoop · Golden Circle1 hit